Office of the Commissioner of Lobbying of Canada Office of the Commissioner of Lobbying of Canada

Language selection

Registry of Lobbyists

Monthly Communication Reports in the last 6 Months for GlaxoSmithKline Inc.

Sridhar Venkatesh, General Manager and President (Corporation)

Learn more...

Registrants are required to submit a monthly communication report for each oral and arranged communication with a designated public office holder. The name of the most senior paid officer (i.e. the registrant) will appear on all in-house monthly communication reports, whether or not he/she participated in the communication.

Note: Monthly Communication Reports are due on the 15th day of each month for communications that took place in the previous month.

Results below are sorted by posted date, beginning with the most recent.

Results null-null of 15

  • GlaxoSmithKline Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Rodrigo Arancibia, Director | Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Government Procurement, Health, International Trade, Budget, Economic Development
    Communication date: 2025-03-28
    Posted date: 2025-04-15
    Communication number: 5088-634111 View monthly communication report
  • GlaxoSmithKline Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Stephen Ellis, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Economic Development
    Communication date: 2025-03-03
    Posted date: 2025-04-15
    Communication number: 5088-632149 View monthly communication report
  • GlaxoSmithKline Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Ritu Banerjee, Assistant Deputy Minister | Director General's Office | Innovation, Science and Economic Development Canada (ISED)
    • Melissa Sutherland, Director General | Pandemic Preparation Coordination Directorate | Health Canada (HC)

    Subject Matter of the communication: Health, Economic Development
    Communication date: 2025-02-26
    Posted date: 2025-03-15
    Communication number: 5088-632053 View monthly communication report
  • GlaxoSmithKline Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Erin Henry, Director General | Centre for Immunization Programs | Public Health Agency of Canada (PHAC)
    • Matthew Tunis, Executive Secretary | National Advisory Committee on Immunization | Public Health Agency of Canada (PHAC)
    • Heather Deehan, Director | Centre for Vaccines and Therapeutic Readiness | Public Health Agency of Canada (PHAC)
    • Michael Pignat, Manager, Procurement | Infectious Diseases and Vaccination Programs Branch | Public Health Agency of Canada (PHAC)

    Subject Matter of the communication: Health, International Trade, Economic Development
    Communication date: 2025-02-25
    Posted date: 2025-03-15
    Communication number: 5088-631897 View monthly communication report
  • GlaxoSmithKline Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Rodrigo Arancibia, Director | Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
    • Jocelyn Milburn, Director | Office of Life Sciences and Biomanufacturing Readiness | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, International Trade, Economic Development
    Communication date: 2025-02-13
    Posted date: 2025-03-15
    Communication number: 5088-631066 View monthly communication report
  • GlaxoSmithKline Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Eric Nicol, Director of Policy | Employment and Social Development Canada (ESDC)

    Subject Matter of the communication: Health
    Communication date: 2025-02-10
    Posted date: 2025-03-15
    Communication number: 5088-630534 View monthly communication report
  • GlaxoSmithKline Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Ritu Banerjee, Assistant Deputy Minister | Director General's Office | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Government Procurement, Health, Budget, Economic Development
    Communication date: 2025-01-13
    Posted date: 2025-02-15
    Communication number: 5088-628541 View monthly communication report
  • GlaxoSmithKline Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Ritu Banerjee, Assistant Deputy Minister | Director General's Office | Innovation, Science and Economic Development Canada (ISED)
    • Kasondra White, Director | Office of Life Sciences and Biomanufacturing Readiness | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Economic Development
    Communication date: 2024-12-09
    Posted date: 2025-01-15
    Communication number: 5088-625161 View monthly communication report
  • GlaxoSmithKline Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Laurel Chester, Sr Advisor | Minister of Innovation, Science and Industry | Innovation, Science and Economic Development Canada (ISED)
    • Philip Jennings, Deputy Minister | Innovation, Science and Economic Development Canada (ISED)
    • François-Philippe Champagne, Minister | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Research and Development, Economic Development
    Communication date: 2024-11-29
    Posted date: 2024-12-16
    Communication number: 5088-624281 (amended from 5088-624278) View monthly communication report
  • GlaxoSmithKline Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Erin Henry, Director General | Centre for Immunization Programs | Public Health Agency of Canada (PHAC)
    • Jacqueline Kosche, Director, Vaccine Logistics and Operations | Public Health Agency of Canada (PHAC)
    • Natalie Gravelle, A/ Director | Centre for Immunization Programs | Public Health Agency of Canada (PHAC)

    Subject Matter of the communication: Health
    Communication date: 2024-11-27
    Posted date: 2024-12-16
    Communication number: 5088-625162 View monthly communication report
  • GlaxoSmithKline Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Mohamed-Iqbal Ravalia, Senator | Senate of Canada

    Subject Matter of the communication: Government Procurement, Health, Budget, Economic Development
    Communication date: 2024-11-27
    Posted date: 2024-12-16
    Communication number: 5088-624050 View monthly communication report
  • GlaxoSmithKline Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Greg Orencsak, Deputy Minister | Health Canada (HC)
    • Jill Norman , Director | Centre for Communicable Diseases and Infection Control | Health Canada (HC)
    • Amanda Ratz, Senior Advisor | Deputy Minister's Office | Health Canada (HC)

    Subject Matter of the communication: Government Procurement, Health, Immigration, Budget, Economic Development
    Communication date: 2024-11-26
    Posted date: 2024-12-16
    Communication number: 5088-623995 View monthly communication report
  • GlaxoSmithKline Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Mark Holland, Minister of Health | Health Canada (HC)
    • Eshan Naik, Director of Policy | Minister's office | Health Canada (HC)

    Subject Matter of the communication: Government Procurement, Health, Budget, Economic Development
    Communication date: 2024-11-26
    Posted date: 2024-12-16
    Communication number: 5088-623994 View monthly communication report
  • GlaxoSmithKline Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Jean-Yves Duclos, Member of Parliament | House of Commons
    • Loic Pare, Regional Affairs Advisor | Public Services and Procurement Canada (PSPC)

    Subject Matter of the communication: Government Procurement, Health
    Communication date: 2024-11-22
    Posted date: 2024-12-16
    Communication number: 5088-623913 View monthly communication report
  • GlaxoSmithKline Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Ritu Banerjee, Assistant Deputy Minister | Director General's Office | Innovation, Science and Economic Development Canada (ISED)
    • Heather Earle, Manager | Life Sciences and Biomanufacturing Branch | Innovation, Science and Economic Development Canada (ISED)
    • Bryan Dalphy, Deputy Director | Life Sciences and Biomanufacturing Branch | Innovation, Science and Economic Development Canada (ISED)
    • Kasondra White, Director | Office of Life Sciences and Biomanufacturing Readiness | Innovation, Science and Economic Development Canada (ISED)
    • Simon Young, Senior Policy Analyst | Life Sciences and Biomanufacturing Branch | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health
    Communication date: 2024-11-05
    Posted date: 2024-12-16
    Communication number: 5088-620076 View monthly communication report
Date Modified: